A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Princy N Kumar, MD
Georgetown University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mills Clinical Research
Los Angeles, California, United States
- Ruane Clinical Research
Los Angeles, California, United States
- Bios Clinical Research
Palm Springs, California, United States
- Uc San Diego Owen Clinic
San Diego, California, United States
- Yale University
New Haven, Connecticut, United States
- Circle Care Center
Stamford, Connecticut, United States
- Waterbury Hospital
Waterbury, Connecticut, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Whitman Walker Health
Washington D.C., District of Columbia, United States
- Aids Healthcare Foundation
Fort Lauderdale, Florida, United States
- Gary J. Richmond, M.D., Pa
Fort Lauderdale, Florida, United States
- Midway Specialty Care Center Miami Beach
Miami Beach, Florida, United States
- Bliss Health
Orlando, Florida, United States
- Orlando Immunology Center (oic)
Orlando, Florida, United States
- Can Community Health
Tampa, Florida, United States
- Can Community Health
Tampa, Florida, United States
- St-Joseph'S Comprehensive Research
Tampa, Florida, United States
- Triple O Research Institute Pa
West Palm Beach, Florida, United States
- Indiana University Health Inc.
Bloomington, Indiana, United States
- University of Maryland School of Medicine
Baltimore, Maryland, United States
- Boston Medical Center
Boston, Massachusetts, United States
- the Research Institute
Springfield, Massachusetts, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Las Vegas Research Center
Las Vegas, Nevada, United States
- I.D. Care Associates, Pa
Hillsborough, New Jersey, United States
- Prime Healthcare Services - St Michael'S Medical Center
Newark, New Jersey, United States
- Suny Upstate Medical Center
Syracuse, New York, United States
- Amity Medical Group
Charlotte, North Carolina, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- the Roper St. Francis Ryan White Wellness Center
Charleston, South Carolina, United States
- North Texas Infectious Diseases Consultants, P.A
Dallas, Texas, United States
- Prism Health North Texas
Dallas, Texas, United States
- Legacy Community Pharmacy Services
Houston, Texas, United States
- St. Hope Foundation
Houston, Texas, United States
- Therapeutic Concepts, Pa
Houston, Texas, United States
- Ut Health Houston
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Mar 2022
- Primary completion
- 30 Jun 2026
- Completion
- 30 Jun 2026
- Last update posted
- 2 Jan 2026
- Registered enrollment
- 168
- Registry id
- NCT05388474
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.